A detailed history of Hemenway Trust CO LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Hemenway Trust CO LLC holds 7,278 shares of MRNA stock, worth $397,669. This represents 0.08% of its overall portfolio holdings.

Number of Shares
7,278
Previous 7,243 0.48%
Holding current value
$397,669
Previous $771,000 12.06%
% of portfolio
0.08%
Previous 0.07%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$101.21 - $166.61 $3,542 - $5,831
35 Added 0.48%
7,278 $864,000
Q1 2024

May 03, 2024

BUY
$85.37 - $115.44 $103,553 - $140,028
1,213 Added 20.12%
7,243 $771,000
Q4 2023

Feb 12, 2024

BUY
$69.51 - $104.43 $156,049 - $234,445
2,245 Added 59.31%
6,030 $599,000
Q3 2023

Nov 13, 2023

SELL
$96.41 - $126.61 $31,333 - $41,148
-325 Reduced 7.91%
3,785 $390,000
Q2 2023

Aug 11, 2023

BUY
$118.5 - $160.53 $277,408 - $375,800
2,341 Added 132.33%
4,110 $499,000
Q1 2023

May 10, 2023

BUY
$135.66 - $197.02 $239,982 - $348,528
1,769 New
1,769 $271,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $21.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Hemenway Trust CO LLC Portfolio

Follow Hemenway Trust CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hemenway Trust CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hemenway Trust CO LLC with notifications on news.